Lixte Biotechnology Holdings Inc (LIXT)
2.98
+0.10
(+3.40%)
USD |
NASDAQ |
May 03, 09:51
Lixte Biotechnology Holdings Cash from Operations (TTM): -4.293M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.293M |
| September 30, 2023 | -4.600M |
| June 30, 2023 | -4.829M |
| March 31, 2023 | -4.848M |
| December 31, 2022 | -4.612M |
| September 30, 2022 | -4.550M |
| June 30, 2022 | -4.304M |
| March 31, 2022 | -4.152M |
| December 31, 2021 | -4.143M |
| September 30, 2021 | -3.735M |
| June 30, 2021 | -3.431M |
| March 31, 2021 | -2.744M |
| December 31, 2020 | -2.131M |
| September 30, 2020 | -1.770M |
| June 30, 2020 | -1.734M |
| March 31, 2020 | -1.709M |
| December 31, 2019 | -1.674M |
| September 30, 2019 | -1.873M |
| June 30, 2019 | -1.450M |
| March 31, 2019 | -1.393M |
| December 31, 2018 | -1.511M |
| September 30, 2018 | -1.219M |
| June 30, 2018 | -1.514M |
| March 31, 2018 | -1.581M |
| December 31, 2017 | -1.412M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.598M |
| June 30, 2017 | -1.617M |
| March 31, 2017 | -1.681M |
| December 31, 2016 | -1.677M |
| September 30, 2016 | -1.820M |
| June 30, 2016 | -1.849M |
| March 31, 2016 | -1.968M |
| December 31, 2015 | -2.181M |
| September 30, 2015 | -2.213M |
| June 30, 2015 | -2.042M |
| March 31, 2015 | -1.815M |
| December 31, 2014 | -1.636M |
| September 30, 2014 | -1.307M |
| June 30, 2014 | -1.254M |
| March 31, 2014 | -1.259M |
| December 31, 2013 | -1.180M |
| September 30, 2013 | -1.090M |
| June 30, 2013 | -1.101M |
| March 31, 2013 | -1.237M |
| December 31, 2012 | -1.206M |
| September 30, 2012 | -1.546M |
| June 30, 2012 | -1.654M |
| March 31, 2012 | -1.532M |
| December 31, 2011 | -1.360M |
| September 30, 2011 | -0.9978M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-4.848M
Minimum
Mar 2023
-1.450M
Maximum
Jun 2019
-3.294M
Average
-3.735M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| iBio Inc | -18.89M |
| PAVmed Inc | -52.04M |
| PDS Biotechnology Corp | -33.64M |
| Moleculin Biotech Inc | -24.10M |
| Syros Pharmaceuticals Inc | -109.71M |